Inequality in India is worsening and clearly following the US pattern India is a “relatively low-income inequality country” – to borrow an expression from a World Bank publication – when compared to China or Brazil, but there is no doubt that disparities have been widening of late. Planning Commission officials have admitted that inequality has risen in the first decade of the new millennium, although the factors responsible for it need...
More »SEARCH RESULT
A bound-to-fail positive effort-Panini Anand
THE DEBATE on the National Food Security Bill, tabled in parliament three months ago, is on full swing. Economists from both sides are arming their arguments with facts and logic. The people who would benefit of this legislation are in a dilemma. This prompts the consideration that the experts must try to see the issue from the ground reality of food security and its beneficiaries. Undoubtedly, it’s a great and historical...
More »‘Inequality has gone up, notwithstanding dip in poverty'-K Balchand
Montek Singh says he is willing to revise poverty estimates on the basis of expert opinion Though the incidence of poverty has come down over five years from 2004-05 to 2009-10, it is a startling fact that inequality has increased, with fewer people controlling income. Union Planning Commission Deputy Chairman Montek Singh Ahluwalia admitted on Tuesday that income distribution was not at the desired level and inequality increased in both rural and...
More »India patent bypass delivers life-saving blow against cancer by Raja Murthy
India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...
More »Cheap generics no panacea for India's poorest
-Reuters Cheap generic drugs were meant to change the life of Nandakhu Nissar, whose mouth is swollen by a cancerous tumour. But the cashless and hungry 55-year-old sleeps on a pavement staring up at the windows of Mumbai's biggest cancer hospital. "What is a generic drug?" shrugs Nissar, who has travelled over 1,500 kms (900 miles) from his home in the hope of treatment. "I have borrowed money from friends and relatives...
More »